Canadian General Medical Center Complex Company (TADAWUL:4021)
Saudi Arabia
· Delayed Price · Currency is SAR 5.64
+0.05 (0.89%)
At close: Mar 5, 2026
TADAWUL:4021 Income Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Revenue | 134.39 | 110.8 | 100.34 | 81.23 | 70.64 | 64.22 |
| Revenue Growth (YoY) | 24.43% | 10.42% | 23.53% | 14.99% | 10.01% | - |
| Cost of Revenue | 94.85 | 82.36 | 68.8 | 56.26 | 45.51 | 40.19 |
| Gross Profit | 39.54 | 28.45 | 31.54 | 24.97 | 25.13 | 24.03 |
| Selling, General & Admin | 18.81 | 16.64 | 9.51 | 7.28 | 8.45 | 7.03 |
| Operating Expenses | 19.53 | 17.02 | 15.98 | 7.88 | 8.95 | 7.03 |
| Operating Income | 20.01 | 11.43 | 15.56 | 17.09 | 16.19 | 16.99 |
| Interest Expense | -0.57 | -0.51 | -0.33 | -0.56 | -0.35 | -0.39 |
| Interest & Investment Income | 1.83 | 1.83 | 2.4 | 0.97 | - | - |
| Other Non Operating Income (Expenses) | -1.6 | 0.08 | 0.27 | 0.25 | 0.31 | 0.11 |
| EBT Excluding Unusual Items | 19.67 | 12.83 | 17.91 | 17.75 | 16.14 | 16.72 |
| Gain (Loss) on Sale of Investments | -1.28 | 0.07 | - | 0.23 | 0.38 | - |
| Gain (Loss) on Sale of Assets | -0.01 | -0.01 | -0.04 | -0 | 0 | -0.01 |
| Pretax Income | 18.38 | 12.89 | 17.86 | 17.97 | 16.53 | 16.71 |
| Income Tax Expense | 2.15 | 2.63 | 2.15 | 2.32 | 2.47 | 0.56 |
| Net Income | 16.23 | 10.27 | 15.71 | 15.65 | 14.06 | 16.15 |
| Net Income to Common | 16.23 | 10.27 | 15.71 | 15.65 | 14.06 | 16.15 |
| Net Income Growth | 68.05% | -34.63% | 0.36% | 11.31% | -12.94% | - |
| Shares Outstanding (Basic) | 77 | 77 | 77 | 77 | 77 | 4 |
| Shares Outstanding (Diluted) | 77 | 77 | 77 | 77 | 77 | 4 |
| Shares Change (YoY) | - | - | - | - | 1900.35% | - |
| EPS (Basic) | 0.21 | 0.13 | 0.20 | 0.20 | 0.18 | 4.20 |
| EPS (Diluted) | 0.21 | 0.13 | 0.20 | 0.20 | 0.18 | 4.20 |
| EPS Growth | 68.05% | -34.63% | 0.36% | 11.31% | -95.65% | - |
| Free Cash Flow | 4.56 | -3.9 | 9.39 | 16.43 | -0.05 | 16.73 |
| Free Cash Flow Per Share | 0.06 | -0.05 | 0.12 | 0.21 | -0.00 | 4.35 |
| Dividend Per Share | 0.100 | 0.050 | 0.190 | 0.200 | 0.300 | - |
| Dividend Growth | 122.22% | -73.68% | -5.00% | -33.33% | - | - |
| Gross Margin | 29.43% | 25.67% | 31.43% | 30.74% | 35.58% | 37.41% |
| Operating Margin | 14.89% | 10.31% | 15.51% | 21.04% | 22.91% | 26.46% |
| Profit Margin | 12.07% | 9.27% | 15.66% | 19.27% | 19.91% | 25.15% |
| Free Cash Flow Margin | 3.40% | -3.52% | 9.36% | 20.23% | -0.06% | 26.06% |
| EBITDA | 23.21 | 13.43 | 16.48 | 19.01 | 18.42 | 19.12 |
| EBITDA Margin | 17.27% | 12.12% | 16.42% | 23.41% | 26.08% | 29.77% |
| D&A For EBITDA | 3.19 | 2 | 0.92 | 1.92 | 2.23 | 2.13 |
| EBIT | 20.01 | 11.43 | 15.56 | 17.09 | 16.19 | 16.99 |
| EBIT Margin | 14.89% | 10.31% | 15.51% | 21.04% | 22.91% | 26.46% |
| Effective Tax Rate | 11.70% | 20.36% | 12.05% | 12.90% | 14.92% | 3.34% |
| Advertising Expenses | - | - | 0.02 | - | - | - |
Source: S&P Capital IQ. Standard template. Financial Sources.